The Muscular Dystrophy Association celebrates this new more accessible treatment option for people living with SMA. MDA - New ...
A scheduled charity wrestling event in August will bring a famous name from pro wrestling, who's also a former gold medalist, ...
US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
The University of Rochester will confront significant blows to groundbreaking clinical studies, UR says in a legal challenge to cuts in NIH funding.
Zacks Small Cap Research on MSN3h
ARWR: Multiple Catalysts Ahead in 2025…Part 1 of the trial will assess single and multiple doses of ARO-INHBE monotherapy, while Part 2 of the study will assess ARO-INHBE in combination with tirzepatide. We anticipate results from Part 1 ...
Duchenne muscular dystrophy (DMD) is a rare hereditary disease that is associated with progressive muscle wasting. The ...
The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback